Dr. Alina Gerrie, MD MPH FRCPC

Dr. Alina Gerrie is a hematologist and Assistant Professor in the Divisions of Hematology and Medical Oncology at the University of British Columbia (UBC) and a Clinician Investigator at the Centre for Lymphoid Cancer at BC Cancer. She is a faculty member in the Interdisciplinary Oncology Program (IOP) and Department of Experimental Medicine at UBC. Dr. Gerrie completed her medical degree and internal medicine residency at the University of Toronto, followed by hematology residency at UBC. She undertook a fellowship through the Royal College Clinical Investigator Program and earned a Master’s of Public Health degree from Harvard University, where her research included investigating the impact of genetic abnormalities on population-level outcomes in chronic lymphocytic leukemia (CLL) patients.

Dr. Gerrie is involved in translational, clinical trial and outcomes-based research related to leukemia and lymphoma. Other academic interests include the investigation of novel therapeutics and stem cell transplant for chronic lymphocytic leukemia (CLL) and lymphoma and improving long-term outcomes for lymphoma and stem cell transplant survivors. Dr. Gerrie currently holds a Michael Smith Health Research Investigator Award and grant funding through the Mitacs Accelerate Program and Cancer Research Society. She is a co-investigator on a Genome Canada Large-Scale Applied Research Project (LSARP) to advance personalized treatments of lymphoid cancer patients in collaboration with Drs. Christian Steidl and David Scott, and is a collaborator on a number of CIHR grants and industry-sponsored clinical trials.

Dr. Gerrie is a member of the BC Provincial CAR T-cell Steering Committee, Lead for Complex Immunotherapy at BC Cancer, and a member of the International Working Group on CLL (IWCLL) Global Partnership committee.

Research Interests: 

• Leukemia
• Lymphoma
• Immune System
• Cellular therapy
• Chronic Lymphocytic Leukemia
• Genetics